{"url_path":"/sec/rxst/8-k/2026-07-06/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-06","source_url":"https://www.sec.gov/Archives/edgar/data/1111485/0001193125-26-296200-index.html","accession_number":"0001193125-26-296200","cik":"0001111485","ticker":"RXST","issuer_name":"RxSight, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1111485/0001193125-26-296200-index.html","primary_entity_key":"0001111485","primary_entity_name":"RxSight, Inc."},"word_count":128,"has_tables":true,"body_markdown":"##  \n\n## Item 2.02 Results of Operations and Financial Condition.\n\nOn July 6, 2026, RxSight, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited second quarter financial and operational results. A copy of the press release is furnished herewith as Exhibit 99.1.\n\nIn accordance with General Instruction B.2 of Form 8-K, the information furnished in this Current Report on Form 8-K under Item 2.02 and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or in any filing under the Exchange Act, except as shall be expressly set forth by specific reference in such a filing."}